J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India flag India · Delayed Price · Currency is INR
1,706.10
+10.70 (0.63%)
At close: Jul 25, 2025

J. B. Chemicals & Pharmaceuticals Company Description

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.

In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services.

It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas.

J. B.

Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

J. B. Chemicals & Pharmaceuticals Limited
CountryIndia
Founded1976
IndustryPharmaceutical Preparations
Employees5,304
CEONikhil Chopra

Contact Details

Address:
Cnergy IT Park
Mumbai, Maharashtra 400025
India
Phone91 22 2439 5200
Websitejbpharma.com

Stock Details

Ticker Symbol506943
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Nikhil ChopraChief Executive Officer
Narayan SarafChief Financial Officer
Kunal KhannaChief Operating Officer